As of Feb 05
| -0.06 / -3.23%|
The 5 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 2.75, with a high estimate of 5.00 and a low estimate of 2.50. The median estimate represents a +52.78% increase from the last price of 1.80.
The current consensus among 5 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since February, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.